Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV-associated nephropathy

By: Bettina Naef, Jakob Nilsson, Rudolf P. Wuethrich, Thomas F. Mueller, Thomas Schachtner

Published: in Transplant International 2021; Volume34, Issue8, August 2021, Pages 1481-1493.

Patients: 860

Highlights:

  • Independent Swiss kidney transplant cohort
  • Transplants with low-level BKV-DNAemia had significantly higher median total PIRCHE if developed TCMR or ABMR